September 7th, 2013
Visit-to-Visit Variability in Systolic BP Among Patients with Type 2 Diabetes
John Chalmers, MD phD and John Ryan, MD
John Chalmers and his coauthors discuss their analysis of data from the ADVANCE trial.
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy